| Financial Year |
March 31 2020 |
| Monetary Funds |
3,955,458.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
21,592,248.35 |
| Advances to Suppliers |
210,561.28 |
| Other Receivables |
1,090,178.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,960,171.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,537,088.88 |
| Total Current Assets |
36,345,706.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,522,481.24 |
| Investment Properties |
16,473,537.78 |
| Fixed Assetes |
95,131,904.82 |
| Under-construction Projects |
24,204,590.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,571,552.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
160,929,066.70 |
| Total Assets |
197,274,773.42 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
27,365,251.41 |
| Accounts Received In Advance |
1,205,663.47 |
| Employee Compensation Payable |
344,005.72 |
| Taxes Payable |
650,396.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,837,488.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
87,402,805.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
664,430.00 |
| Total Liabilities |
88,067,235.61 |
| Paid-In Capital(Or Share Stock) |
343,980,000.00 |
| Capital Surplus |
363,196,406.83 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-597,968,869.02 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
109,207,537.81 |
| Owner's Equity（Stockholder's Equity） |
109,207,537.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
197,274,773.42 |
